eISSN: 2084-9834
ISSN: 0034-6233
Reumatologia/Rheumatology Supplements
Bieżący suplement Archiwum Reumatologia
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
Portal dla reumatologów!
Poleć ten artykuł:
streszczenie artykułu:

Between COVID-19 severity and its prevention – what should rheumatologists be aware of?

Joanna Makowska
Filip Styrzyński

  1. Department of Rheumatology, Medical University of Lodz, Poland
Data publikacji online: 2021/09/08
Pełna treść artykułu Pobierz cytowanie

A year has passed since the unprecedented eruption of SARS-CoV-2 infections affected almost all countries around the world. Rheumatic patients represent a numerous group of people in which the immune system is impaired both by chronic immunosuppressive treatment and by the disease itself. For this reason doctors are worried about the optimal management and how to prevent the exacerbation of autoimmune systemic diseases.

Recently, a few important studies have been published regarding the risk of a severe course of COVID amongst rheumatic patients, parallel to the dynamically ongoing worldwide vaccination process as never seen before.
© 2024 Termedia Sp. z o.o.
Developed by Bentus.